Horizon Pharma reported $26.63B in Market Capitalization this October of 2023, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
ALKERMES USD 4.72B 725M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
AstraZeneca USD 215.51B 41B Jun/2025
Bausch Health Companies USD 3.36B 87.55M Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis USD 256.18B 64.49B Jun/2025
Pacira USD 1.11B 43M Jun/2025
Perrigo USD 3.65B 177M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Prestige Brands USD 3.93B 325M Jun/2025
Supernus Pharmaceuticals USD 1.76B 65M Jun/2025
Takeda JPY 7.04T 19.15B Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025
Zoetis USD 69.43B 4.01B Jun/2025